Ember Therapeutics
Ember Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing regenerative medicines utilizing Bone Morphogenetic Protein-7 (BMP-7) and its related variants. The company aims to address disease modification in osteoarthritis, reverse insulin resistance, and inhibit organ fibrosis in conditions such as chronic kidney disease and Alport syndrome, as well as tackle metabolic diseases like obesity and type 2 diabetes. Ember's lead product candidates include MT-006, which has completed a Phase 2a clinical trial for osteoarthritis, and several other candidates that have successfully completed preclinical trials for various indications. Additionally, Ember holds approximately 450 patents related to BMP-7, covering a broad spectrum of formulations and delivery technologies. Founded in 2010 and headquartered in New York, Ember Therapeutics leverages recent advancements in brown fat biology to develop innovative treatments that enhance the body's ability to metabolize glucose while minimizing side effects associated with existing therapies.
DermaSilk Brands, Inc. is a manufacturer of anti-aging cosmetic products and nutritional supplements, focusing on solutions for aging skin, eyes, face, neck, and wrinkles. The company's product range includes facial masks, collagen lifts, wrinkle erase pens, beauty peels, face lifts, neck lifts, eye lifts, night repairing face lifts, and various skin perfecting solutions. These products are designed to address common signs of aging and enhance skin appearance. DermaSilk Brands sells its offerings through retail stores and is headquartered in New Brunswick, New Jersey. As of September 2016, it operates as a subsidiary of Ember Therapeutics, Inc.
Migralex, Inc. is a New York-based company that develops and sells over-the-counter medications specifically designed for headache relief. Founded in 1992 and currently operating as a subsidiary of Ember Therapeutics, Migralex offers a unique headache remedy that does not contain caffeine, distinguishing it from many other headache medications that often include this stimulant. The company's product addresses various types of headaches, including tension, sinus, stress, menstrual, and hangover headaches. Migralex distributes its products through retail outlets and online platforms, making it accessible to a wide range of consumers seeking effective headache relief without the potential complications associated with caffeine consumption.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.